Ignite Creation Date:
2025-12-18 @ 9:03 AM
Ignite Modification Date:
2025-12-23 @ 6:43 PM
Study NCT ID:
NCT00903682
Status:
None
Last Update Posted:
2013-01-14 00:00:00
First Post:
2009-05-14 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-14 00:00:00
First Submit QC Date:
None
Study First Post Date:
2009-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-02-10 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2011-03-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-07 00:00:00
Last Update Post Date:
2013-01-14 00:00:00
Last Update Post Date Type:
ESTIMATED